Elsevier is Meeting Today’s Medical Students’ Needs With Online, Mobile and Print Tools

Company Celebrates Medical Education Innovation at AMSA's 60th Anniversary Convention

PHILADEPHIA, February 22, 2010 – Elsevier, the leading publisher of scientific, technical and medical
information, today announced it is celebrating medical education innovation
at the American Medical Student Association's (AMSA) 60th Annual Convention
(www.amsa.org/AMSA/Homepage/Events/Convention.aspx), March 11-14,
2010, at the Disneyland Hotel in Anaheim, California.
"Elsevier is [...]

Retacrit(TM) to be the 1st Biosimilar Epoetin to Achieve Subcutaneous Licence in Renal Patients

Retacrit(TM) Received a Positive Opinion From the European Committee for Medicinal Products for Human Use (CHMP) for Subcutaneous (SC) use in Renal Anaemia

LONDON, February 22, 2010 – Hospira announced today that the European Committee for Medicinal
Products for Human Use (CHMP) has recommended for approval the administration
of Retacrit (epoetin zeta) subcutaneously in the nephrology setting. [...]

ConvaTec Introduces Flexi-Seal(R)(TM) SIGNAL(TM) FMS

A new solution from the Flexi-Seal(R)(TM) FMS family of fecal management systems that helps clinicians seal their patients' protection

SKILLMAN, New Jersey, February 22, 2010 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, announced today the launch of
Flexi-Seal(R)(TM) SIGNAL(TM) Fecal Management System (FMS). Now available in
the U.S., U.K. [...]

Newton Gets 2 Years for World-First hGH Positive Finding

LONDON, February 22, 2010 – In a major breakthrough in the international fight against doping in
sport, UK Anti-Doping today announced the first case of human growth hormone
(hGH)* resulting in an athlete sanction.

Wakefield Trinity Wildcats player Terry Newton has accepted a 2-year
sanction for the presence of hGH in a blood sample [...]

Chiltern Announces Partnership With Charles River

LONDON, February 22, 2010 – Chiltern International Limited, a global contract research organization
(CRO), announced its latest collaboration with Charles River Laboratories,
Inc. As part of this collaboration, Chiltern Early Phase will partner with
Charles River to conduct and support early phase radiolabelled studies.

Glenn Kerkhof, Chiltern CEO, stated, "This new partnership is an [...]

Torchmark Corporation to Present at Bank of America Merrill Lynch Insurance Conference

MCKINNEY, Texas, February 22, 2010 – Torchmark Corporation (NYSE: TMK) announced today that its Chief
Executive Officer, Mark McAndrew, and Chief Financial Officer, Gary Coleman,
will present Tuesday, February 23, 2010 at the Bank of America Merrill Lynch
Insurance Conference in New York City. Torchmark's presentation is scheduled
to begin at 8:35 a.m. EST.

[...]